Skip to main content

Table 2 Individual data on the eight patients included in the study

From: The incretin effect in critically ill patients: a case–control study

Patient Reason for admission to the ICU Sex APACHE II Data from IVGI OGTT on day after admission Discharge destination Days in ICU Ventilator OGTT/IVGI Mean/median (interquartile range) blood glucose 36 h before OGTT (mmol/L) Total dose of insulin 36 h before OGTT (IU) Total dose of steroida in ICU before OGTT (mg) Dose of steroida OGTT/IVGI (mg/day) Dose of NE OGTT/IVGI (mg/kg/day)
1 Sepsis (pneumonia) Male 27 No 2 Ward 2.8 Yes 8.2/7.7(6.4–8.7) None 18.7 3.7 None/
2 Sepsis (pneumonia) Female 34 Yes 2 Deceased 4.4 Yes/Yes 9.0/7.7(6.4–10.3) 2 None None/11.2 0.53/1.15
3 Sepsis (diverticulitis) Male 23 No 2 Ward 9.0 No 10.4/9.7(9.1–11.3) None None None/ None/
4 Cardiogenic shock Female 25 Yes 2 ICU at another hospital 2.0 No/No 11.9/11.3(10.1–12.1) None 5.6 5.6/None None/None
5 Hypothermia after cardiac arrest Male 41 Yes 4 Deceased 5.2 Yes/Yes 8.1/8.4(7.9–9.4) 63 None None/None None/None
6 Sepsis (pneumonia) Female 45 Yes 3 Deceased 4.1 Yes/Yes 8.2/7.4(6.6–8.5) None 18.8 None/None 0.04b/0.59
7 Sepsis (pneumonia) Male 31 Yes 2 Ward 12.7 No/Yes 7.2/7.6(7.1–8.7) None None None/None None/None
8 Sepsis (pneumonia) Female 24 Yes 3 Ward 14.4 Yes/Yes 9.5/9.4 (7.9–10.9) 48 11.2 5.6/5.6 0.04/0.20
Mean/median (interquartile range)    31/28 (24–38)     6.8/4.8 (3.5–10.8)   9.1/8.6 (8.1–9.9) 14.1/0.0 (0.0–25.0) 6.8/2.8 (0.0–15.0) 1.8/0.0 (0.0–4.7)/2.8/0.0 (0.0–5.6) 0.08/0.00 (0.00–0.04)/0.32/0.10 (0.0–0.59)
  1. APACHE Acute Physiology and Chronic Health Evaluation, ICU intensive care unit, IVGI intravenous glucose infusion, NE norepinephrine, OGTT oral glucose tolerance test, IU International Units
  2. Patients on the ventilator included intubated patients and patients receiving noninvasive ventilation.
  3. aDose equipotent to dexamethasone
  4. bThis patients also received 22 mg/kg/day of dopamine infusion on this day